Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders

A technology of arylpiperazine and derivatives, which is applied in the field of arylpiperazine derivatives, and can solve problems such as no reports of arylpiperazine derivatives

Inactive Publication Date: 2009-10-28
UNIV DEGLI STUDI DI ROMA LA SAPIENZA
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the arylpiperazine derivatives of the present invention have not been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders
  • Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders
  • Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0083] Preparation Example

[0084] In order to get 5 1 and 5 2 The synthetic strategy followed is reported in Scheme 1 below.

[0085] Commercially available 6-methylquinoline was oxidized to the corresponding quinoline-6-carboxylic acid (2) in acidic medium by using chromium trioxide. The acid 2 was converted to the hydroxyamide 3 by means of a coupling reaction with 4-aminobutanol in the presence of 1-hydroxybenzotriazole (HOBt) and 1,3-dicyclohexylcarbodiimide (DCC). . The latter, following bromination of the hydroxyl group, leads to the bromo-derivative 4, which is treated with the appropriate arylpiperazine in the presence of a base to give the desired product (5 1,2 ).

[0086] plan 1

[0087]

[0088] a) CrO 3 、H 2 O / H 2 SO 4 Reflux; b) 4-amino-1-butanol, EDC, HOBt, TEA, CH 2 Cl 2 dry, rt; c) CBr 4 、PPh 3 、CH 3 CN, rt; d) for 5 1 1-phenylpiperazine or for 5 2 8, TEA, CH 3 CN, reflow.

[0089] Synthesis of 5 was obtained from Boc-piperazine and 1-b...

Embodiment 2

[0122] biological activity

[0123] In vitro binding studies

[0124] The affinity of Compound 5 of the present invention for dopamine and serotonin receptor subtypes was determined by a standard receptor binding assay performed by MDS Pharma Services using the specific assay conditions described below.

[0125] From these assays, compound 5 of the present invention was found to be selective for dopamine D3 with a Ki in the subnanomolar range.

[0126] Dopamine D3 (MDS Catalog No.219800)

[0127] Human Recombinant CHO Cells

[0128] Ligand = 0.7nM [ 3 H]-Spiperone

[0129] Nonspecific = 25 μM S(-)-sulpiride

[0130] 5-hydroxytryptamine 5-HT 1A (MDS Catalog No.271110)

[0131] Human recombinant (CHO cells)

[0132] Ligand = 1.5nM [ 3 H]8-OH-DPAT

[0133] Nonspecific = 10 μM ergobenzyl ester

[0134] 5-hydroxytryptamine 5-HA 2A (MDS Catalog No.271650)

[0135] Human recombinant (CHO cells)

[0136] Ligand = 0.5nM [ 3 H]ketanserin

[0137] Nonspecifi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

This invention provides novel aryl piperazine derivatives represented by Formula (I) having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D3, 5HT1A and 5-HT2A receptor subtypes, and in particular useful for the treatment of neuropsychiatric disorders, incl. schizophrenia.

Description

technical field [0001] The present invention provides novel arylpiperazine derivatives which are useful in medicine, especially as receptors for dopamine and serotonin, preferably D 3 , 5HT 1A and 5-HT 2A Modulators of receptor subtypes, and particularly useful in the treatment of neuropsychiatric disorders including schizophrenia. Background technique [0002] Dopamine is associated with several important excitatory and inhibitory functions in the central and peripheral nervous system via dopaminergic receptors. Dopamine receptors were originally divided into two main classes: D 1 and D 2 . The five dopamine receptors cloned so far belong to the above categories. Therefore, D 1 -like receptors including D 1 and D 5 , while D 2 -like receptors including D 2 、D 3 and D 4 . [0003] dopamine receptors, and in particular D 2 -like receptors are considered as potential therapeutic targets for different neurological and psychiatric disorders, especially psychiatric...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D215/48A61K31/4709A61P25/18
Inventor G·卡姆皮亚尼S·布逖尼C·法特鲁索S·弗朗斯施尼Z·I·萨勒K·S·尼尔森J·施尔-克鲁戈L·S·马德森J·施尔-克鲁戈
Owner UNIV DEGLI STUDI DI ROMA LA SAPIENZA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products